Table 1 TKT staining and clinicopathological characteristics of 74 renal cancer patients.

From: TKT drives renal cell carcinoma progression through metabolic reprogramming and synergistic interaction with PKM2

Variables

TKT staining

Low (%)

High (%)

Total

Pa

All cases

40 (54.05)

34 (45.95)

74

 

Age

 ≤56

22 (64.71)

12 (35.29)

34

0.0659

 >56

17 (42.50)

23 (57.50)

40

 

Gender

 Male

27 (46.00)

23 (54.00)

50

0.8067

 Female

12 (50.00)

12 (50.00)

24

 

Tumor size

 ≤7 cm

31 (62.00)

19 (38.00)

50

0.0265

 >7 cm

8 (33.33)

16 (66.67)

24

 

TNM stage

 T1

32 (66.67)

16 (33.33)

48

0.0015

 T2–T4

7 (26.92)

19 (73.08)

26

 

Tumor Grade

 Ⅰ

32 (69.57)

14 (30.43)

46

0.0003

 Ⅱ-Ⅳ

7 (25.00)

21 (75.00)

28

 
  1. aP values are from χχ2 test.
Back to article page